These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7837727)
1. [Therapeutic efficacy of macrolide in pulmonary nontuberculous mycobacteriosis]. Tomono K Kekkaku; 1994 Nov; 69(11):725-32. PubMed ID: 7837727 [TBL] [Abstract][Full Text] [Related]
2. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice]. Tomioka H; Sato K; Saito H Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119 [TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of pulmonary Mycobacterium kansasii infection]. Mizutani S Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388 [TBL] [Abstract][Full Text] [Related]
4. [Perspective of pulmonary MAC infection treatment]. Kurashima A Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124 [TBL] [Abstract][Full Text] [Related]
5. [The clinical study of clarithromycin for pulmonary Mycobacterium avium-intracellulare complex infection]. Yamamoto M; Kuze F; Sakatani M; Saito H; Shimoide H; Soejima R; Hara K Kekkaku; 1997 Jan; 72(1):1-7. PubMed ID: 9038009 [TBL] [Abstract][Full Text] [Related]
6. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease]. Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597 [TBL] [Abstract][Full Text] [Related]
7. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections]. Kawahara S; Nagare H Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700 [TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection]. Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572 [TBL] [Abstract][Full Text] [Related]
9. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?]. Ogawa K; Sano C Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176 [TBL] [Abstract][Full Text] [Related]
10. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease. Ye JJ; Wu TS; Chiang PC; Lee MH J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469 [TBL] [Abstract][Full Text] [Related]
11. [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis]. Mizutani S Kekkaku; 1998 Feb; 73(2):87-92. PubMed ID: 9545702 [TBL] [Abstract][Full Text] [Related]
13. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo. Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635 [TBL] [Abstract][Full Text] [Related]
14. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease]. Sato K; Ebe T Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891 [TBL] [Abstract][Full Text] [Related]
15. [The short-term effects of multidrug chemotherapy for pulmonary Mycobacterium avium-intracellulare complex (MAC) infection]. Kurashima A Kekkaku; 1998 May; 73(5):371-7. PubMed ID: 9637822 [TBL] [Abstract][Full Text] [Related]
16. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Dautzenberg B; Saint Marc T; Meyohas MC; Eliaszewitch M; Haniez F; Rogues AM; De Wit S; Cotte L; Chauvin JP; Grosset J Arch Intern Med; 1993 Feb; 153(3):368-72. PubMed ID: 8427539 [TBL] [Abstract][Full Text] [Related]
17. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols]. Tomioka H; Saito H Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724 [TBL] [Abstract][Full Text] [Related]
18. [Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens]. Shirai M; Hayakawa H; Nakano Y; Kuroishi S; Nakano Y; Todate A; Suda T; Chida K Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):875-9. PubMed ID: 15566000 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of non-tuberculous pulmonary mycobacteriosis]. Sakatani M; Nakajima Y Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999 [TBL] [Abstract][Full Text] [Related]
20. New developments in the treatment of nontuberculous mycobacterial (NTM) disease. Griffith DE; Wallace RJ Semin Respir Infect; 1996 Dec; 11(4):301-10. PubMed ID: 8976583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]